INFLARX GMBH has a total of 70 patent applications. It increased the IP activity by 1900.0%. Its first patent ever was published in 2009. It filed its patents most often in United States, EPO (European Patent Office) and Republic of Korea. Its main competitors in its focus markets pharmaceuticals, biotechnology and organic fine chemistry are XOMA US LLC, MODIQUEST B V and GENSCI REGENERATION SCIENCES I.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 10 | |
#2 | EPO (European Patent Office) | 7 | |
#3 | Republic of Korea | 6 | |
#4 | China | 5 | |
#5 | WIPO (World Intellectual Property Organization) | 5 | |
#6 | Australia | 4 | |
#7 | Canada | 4 | |
#8 | Israel | 4 | |
#9 | Japan | 4 | |
#10 | Chile | 3 | |
#11 | Singapore | 3 | |
#12 | Brazil | 2 | |
#13 | Hungary | 2 | |
#14 | Mexico | 2 | |
#15 | Serbia | 2 | |
#16 | Taiwan | 2 | |
#17 | EAPO (Eurasian Patent Organization) | 1 | |
#18 | New Zealand | 1 | |
#19 | Peru | 1 | |
#20 | Philippines | 1 | |
#21 | Slovenia | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Peptides | |
#3 | Therapeutic chemical compounds | |
#4 | Heterocyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Guo Renfeng | 59 |
#2 | Riedemann Niels Christoph | 36 |
#3 | Li Yan | 24 |
#4 | Shen Beifen | 23 |
#5 | Riedemann Niels R | 14 |
#6 | Niels Christoph Riedemann | 7 |
#7 | Riedemann Niels C | 7 |
#8 | Yan Li | 5 |
#9 | Beifen Shen | 5 |
#10 | Renfeng Guo | 4 |
Publication | Filing date | Title |
---|---|---|
WO2020182384A1 | Fused piperidinyl bicyclic and related compounds as modulators of c5a receptor | |
US2018280530A1 | Treatment of inflammatory diseases with inhibitors of C5a activity | |
SG11201912882QA | Treatment of inflammatory diseases with inhibitors of c5a activity | |
AU2018249310A1 | Treatment of inflammatory diseases with inhibitors of C5a activity | |
SG11201607740TA | Inhibitors of c5a for the treatment of viral pneumonia | |
EP2327725A1 | Anti-C5a binding moieties with high blocking activity |